News & Articles

The diagnostic assay can be used to help diagnose patients with non-small cell lung cancer

I.W. Tremont CFP-DBS-v1 material for dried blood spot sampling, storage and transport delivers reliable performance for diagnostic applications

SelectScience is heading to Chicago, USA, to interview scientists at the forefront of neuroscience research and report on the latest techniques and technologies advancing the field

AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.

New data show NfL may be a biomarker for predicting future disability outcomes

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis

Abbott's new technology is poised to be the first point-of-care blood test for assessing concussions, providing doctors results in 15 minutes

Following last year’s success, we’re hosting our second annual event dedicated to celebrating our Seals of Quality program

Upgrades include launch of next-generation ReCIVA breath sampler and CASPER portable air supply

Akoya Biosciences determines that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies

Find all the latest developments in antibody engineering and June’s top content from our drug discovery community

From rare pathogens to pandemic prevention, explore the latest techniques and technologies that are shaping today’s diagnosis and treatment of infectious diseases

Based on ESCAPE™ RNA sequencing technology, the latest proteogenomics assay is designed to characterize both RNA and protein expression levels across thousands of single CAR T cells

Avacta’s first Affimer clinical candidate is a potent PD-L1 antagonist under development for solid tumor indications as the basis of bispecific and combination therapies

The Afinion HbA1c Dx test provides results in just three minutes, enabling clinicians to develop informed and individualized patient care plans

Thermo Fisher and Newomics to optimize performance of high-throughput analytical workflows

IMMray™ PanCan-d blood-based test for early detection of pancreatic cancer now set for Q3 2020 launch

A mass spec scientist, from a world-renowned clinical pathology laboratory, shares the secrets to their success in this exclusive SelectScience interview

From cancer biosimilars to AI PCR & the technologies making gene therapy a reality, discover the top trending content that caught the attention of SelectScience readers in April 2019

Lipotype now offers untargeted, global, and absolutely quantitative analysis services in line with GMP regulation

Watch exclusive highlights from the show floor at SLAS2019 as we find out about the latest technologies innovating life sciences discovery